Improving methods to analyze Alzheimer's disease risk and biomarkers
Official title: Statistical methods for analyzing risk of Alzheimer's Disease and biomarker measurements
Funded at Johns Hopkins University · NIH-11131698 · Data updated 2026-11-12
This study is looking at new ways to understand who might be at risk for Alzheimer's disease or mild cognitive impairment, so that people can get more personalized care and support based on their individual risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | May 15, 2025 |
| Project end | January 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $455,274 |
| NIH project number | 1R01AG088637-01A1 |
| Project ID | NIH-11131698 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who are at risk for Alzheimer's disease, particularly those with a family history or other risk factors.
✕Less likely to help
Patients who are already diagnosed with advanced Alzheimer's disease may not benefit from this research.
What this research studies
This research focuses on developing advanced statistical methods to enhance the understanding of Alzheimer's disease (AD) risk and biomarker measurements. By analyzing data from large-scale studies, the team aims to identify individuals at high risk for developing Alzheimer's or mild cognitive impairment (MCI). The methods will allow for better modeling and prediction of disease incidence, which can lead to targeted monitoring and treatment for those at risk. Patients may benefit from more personalized care based on their risk profiles.
Why it matters
Potential benefit: If successful, this research could lead to improved identification and management of individuals at risk for Alzheimer's disease.
How similar studies have gone: Previous research has shown success in using statistical methods to analyze Alzheimer's disease risk, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Wang, Mei Cheng — Johns Hopkins University
- Study coordinator: Wang, Mei Cheng
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.